Natural Killer Cell-Dependent Anti-Fibrotic Pathway in Liver Injury via Toll-Like Receptor-9
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The toll-like receptor-9 (TLR9) agonist cytosine phosphate guanine (CpG), activates hepatic stellate cells (HSCs) and mediates fibrosis. We investigated the TLR9 effects on lymphocyte/HSCs interactions. Liver fibrosis was induced in wild-type (WT) mice by intra-peritoneal carbon-tetrachloride (CCl4) induction for 6 weeks. Fibrotic groups were intravenously treated by a vehicle versus CpG along last 2 weeks. Compared to vehicle-treated fibrotic WT, the in-vivo CpG-treatment significantly attenuated hepatic fibrosis and inflammation, associated with decreased CD8 and increased NK liver cells. In-vitro, co-cultures with vehicle-treated fibrotic NK cells increased HSCs proliferation (P<0.001) while their CpG-treated counterparts achieved a significant decrease. To investigate the role of lymphocytes, TLR9(-/-) mice induced-hepatic fibrosis were used. Although TLR9(-/-) mice manifested lower fibrotic profile as compared to their wild-type (WT) counterparts, senescence (SA-β-Gal activity) in the liver and ALT serum levels were significantly greater. In an adoptive transfer model; irradiated WT and TLR9(-/-) recipients were reconstituted with naïve WT or TLR9(-/-) lymphocytes. The adoptive transfer of TLR9(-/-) versus WT lymphocytes led to increased fibrosis of WT recipients. TLR9(-/-) fibrotic recipients reconstituted with TLR9(-/-) or WT lymphocytes showed no changes in hepatic fibrosis severity or ALT serum levels. TLR9 activation had inconsistent effects on lymphocytes and HSCs. The net balance of TLR9 activation in WT, displayed significant anti-fibrotic activity, accompanied by CD8 suppression and increased NK-cells, activity and adherence to HSCs. The pro-fibrotic and pro-inflammatory properties of TLR9(-/-) lymphocytes fail to activate HSCs with an early senescence in TLR9(-/-) mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Natural killer (NK) cells have an intriguing capacity to clear activated HSCs (91-94).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [92]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“Sections were counterstained with Eosin [15,24,25].”
Toll-like receptors in innate immunity
Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328 · cited 1×
“TLR9, a member of the TLR family, is expressed intracellularly, within endosomal compartments [5], and activates innate immune defenses against viral and bacterial infection upon binding to DNA rich in cytosine phosphate guanine (CpG) motifs [6].”
BackgroundTakeda, K., & Akira, S. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.10.003 · Cited by 2,461
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Self-citationTLR9 signals after translocating from the ER to CpG DNA in the lysosome
Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K. A., Monks, B. G., Knetter, C. F., Lien, E., Nilsen, N. J., Espevik, T., & Golenbock, D. T. (2004) · Nature Immunology · doi:10.1038/ni1028 · Cited by 1,361
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741
Toll‐like receptors and adaptor molecules in liver disease: Update†
Seki, E., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.22306 · Cited by 722 · cited 1×
“TLR9 pathways are involved in the modulation of liver diseases [29].”
BackgroundPaik, Y.-H., Schwabe, R. F., Bataller, R., Russo, M. P., Jobin, C., & Brenner, D. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50182 · Cited by 651
Anti-Fibrotic Activity of NK Cells in Experimental Liver Injury Through Killing of Activated HSC
Melhem, A., Muhanna, N., Bishara, A., Alvarez, C. E., Ilan, Y., Bishara, T., Horani, A., Nassar, M., Friedman, S. L., & Safadi, R. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.025 · Cited by 270 · cited 2×
“While CD8 cells are directly mediating fibrosis [23], NK cells provide an anti-fibrotic role [14,16], suggesting those responses to be TLR9-mediated as well.”
BackgroundSelf-citationApoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9
Watanabe, A., Hashmi, A., Gomes, D. A., Town, T., Badou, A., Flavell, R. A., & Mehal, W. Z. (2007) · Hepatology · doi:10.1002/hep.21867 · Cited by 262
Granule exocytosis mediates immune surveillance of senescent cells
Sagiv, A., Biran, A., Yon, M., Simon, J., Lowe, S. W., & Krizhanovsky, V (2013) · Oncogene · doi:10.1038/onc.2012.206 · Cited by 240 · cited 1×
“Sections were counterstained with Eosin [15,24,25].”
Self-citationToll-Like Receptor 9 Inhibition Confers Protection From Liver Ischemia–Reperfusion Injury
Bamboat, Z. M., Balachandran, V. P., Ocuin, L. M., Obaid, H., Plitas, G., & DeMatteo, R. P. (2010) · Hepatology · doi:10.1002/hep.23365 · Cited by 199
Apoptosis as a Mechanism for Liver Disease Progression
Guicciardi, M. E., & Gores, G. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1267540 · Cited by 184
NKp46-Mediated Killing of Human and Mouse Hepatic Stellate Cells Attenuates Liver Fibrosis
Gur, C., Doron, S., Kfir-Erenfeld, S., Horwitz, E., Abu-tair, L., Safadi, R., & Mandelboim, O. (2012) · Gut · doi:10.1136/gutjnl-2011-301400 · Cited by 173 · cited 1×
“[12,14,19,37].”
Self-citationRole of TLR9 in hepatic stellate cells and experimental liver fibrosis
Gäbele, E., Mühlbauer, M., Dorn, C., Weiß, T. S., Froh, M., Schnabl, B., Wiest, R., Schölmerich, J., Obermeier, F., & Hellerbrand, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.096 · Cited by 155
Muhanna, N., Doron, S., Wald, O., Horani, A., Eid, A., Pappo, O., Friedman, S. L., & Safadi, R. (2008) · Hepatology · doi:10.1002/hep.22413 · Cited by 147
Self-citationToll-Like Receptor Signaling and Liver Fibrosis
Aoyama, T., Paik, Y.-H., & Seki, E. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/192543 · Cited by 137
Girart, M. V., Fuertes, M. B., Domaica, C. I., Rossi, L. E., & Zwirner, N. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3472 · Cited by 131
Amelioration of hepatic fibrosis by NK cell activation
Muhanna, N., Tair, L. A., Doron, S., Amer, J., Azzeh, M., Mahamid, M., Friedman, S., & Safadi, R. (2011) · Gut · doi:10.1136/gut.2010.211136 · Cited by 127
Self-citationp53 is activated in response to disruption of the pre-mRNA splicing machinery
Allende-Vega, N., Dayal, S., Agarwala, U., Sparks, A., Bourdon, J., & Saville, M. K. (2012) · Oncogene · doi:10.1038/onc.2012.38 · Cited by 98
A Mitochondrial Antigen-Antibody System in Cholestatic Liver Disease Detected by Radioimmunoassay
Manns, M., Meyer, K.-H., & Büschenfelde, Z. (1982) · Hepatology · doi:10.1002/hep.1840020102 · Cited by 95
Lichtenegger, F. S., Mueller, K., Otte, B., Beck, B., Hiddemann, W., Schendel, D. J., & Subklewe, M. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044266 · Cited by 84
Jiang, W., Sun, R., Zhou, R., Wei, H., & Tian, Z. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800973 · Cited by 67
Guillerey, C., Mouriès, J., Polo, G., Doyen, N., Law, H., Chan, S. H., Kastner, P., Leclerc, C., & Dadaglio, G. (2012) · Blood · doi:10.1182/blood-2012-02-410936 · Cited by 62
Graubardt, N., Fahrner, R., Trochsler, M., Keogh, A., Breu, K., Furer, C., Stroka, D., Robson, S. C., Slack, E., Candinas, D., et al. (2013) · Hepatology · doi:10.1002/hep.26008 · Cited by 51
Stories of love and hate: innate immunity and host–microbe crosstalk in the intestine
Rosenstiel, P. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835da2c7 · Cited by 49
Liver-Targeted Gene Therapy by SV40-Based Vectors Using the Hydrodynamic Injection Method
Arad, U., Zeira, E., El-Latif, M. A., Mukherjee, S., Mitchell, L., Pappo, O., Galun, E., & Oppenheim, A. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.361 · Cited by 49
Self-citationMiranda, S. R. P., Erlich, S., Visser, J. W. M., Gatt, S., Dagan, A., Friedrich, V. L., & Schuchman, E. H. (1997) · Blood · doi:10.1182/blood.v90.1.444 · Cited by 44
Bridging Innate NK Cell Functions with Adaptive Immunity
Marcenaro, E., Carlomagno, S., Pesce, S., Moretta, A., & Sivori, S. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5632-3_5 · Cited by 42
多孔質多層カーボンナノチューブ/ポリアニリンコア/シェルナノ複合材料の熱電特性
Kun, Z., Davis, M., Jingjing, Q., Louisa, H.-W., & Wang, S. (2012) · Nanotechnology · Cited by 42
Cross-talk between Toll-like receptors 5 and 9 on activation of human immune responses
Merlo, A. C., Calcaterra, C., Ménard, S., & Balsari, A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207100 · Cited by 40
Modulation of NK cell activity by CpG oligodeoxynucleotides
Ballas, Z. K. (2007) · Immunologic Research · doi:10.1007/s12026-007-0066-3 · Cited by 33
Horani, A., Muhanna, N., Pappo, O., Melhem, A., Alvarez, C. E., Doron, S., Wehbi, W., Karussis, D., Friedman, S. L., & Safadi, R. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00137.2006 · Cited by 29
Self-citationLi, Q., Yan, Z., Li, F., Lu, W., Wang, J., & Guo, C. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/26/265101 · Cited by 28
Innate Immunity and Steatohepatitis: A Critical Role of Another Toll (TLR-9)
Gao, B. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.018 · Cited by 27
Sugauchi, F., Wang, R. Y. ‐., Qiu, Q., Jin, B., Alter, H. J., & Shih, J. W.-K. (2006) · The Journal of Infectious Diseases · doi:10.1086/499823 · Cited by 16
Avraham, Y., Amer, J., Doron, S., Abu-Tair, L., Mahamid, M., Khatib, A., Berry, E. M., & Safadi, R. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00191.2011 · Cited by 10
Self-citationIntrahepatic cytokine profile in renal‐transplant patients infected by hepatitis C virus
Kamar, N., Rostaing, L. P. E., Sauné, K., Sèlves, J., Barthe, C., Dubois, M., Alric, L., Durand, D., & Izopet, J. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20387 · Cited by 5
* 8-year experience of enterocutaneous fistulae at a national intestinal failure centre
Rahbour, G., Warusavitarne, J. H., Gabe, S. M., et al. (2011) · Gut · doi:10.1136/gut.2011.239301.186 · Cited by 1
Research works printed but not linked: 2
- N Graubardt, 2012, Promotion of liver regeneration by natural killer cells in mice is dependent on extracellular ATP phosphohydrolysis, Hepatology, 2, 1
- AM Krieg, 2006, Therapeutic potential of Toll-like receptor 9 activation, Nat Rev Drug Discov, 5, 471, 10.1038/nrd2059 · DOI · Paper page
Cited by
Immunology in the liver — from homeostasis to disease
Heymann, F., & Tacke, F. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.200 · Cited by 1,180
Weiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158
Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease
Khanmohammadi, S., & Kuchay, M. S. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106507 · Cited by 108
Fang, F., Marangoni, R. G., Zhou, X., Yang, Y., Ye, B., Shangguang, A., Qin, W., Wang, W., Bhattacharyya, S., Wei, J., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39655 · Cited by 71
Metadata
- Authors
- Abu-Tair, L., Axelrod, J. H., Doron, S., Ovadya, Y., Krizhanovsky, V., Galun, E., Amer, J., & Safadi, R.
- Affiliations
- Hadassah Medical Center (IL)
- Weizmann Institute of Science (IL)
- Corresponding author
- Amer, Johnny
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-12-10
- Volume
- 8
- Issue
- 12
- Pages
- e82571
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3858328
- OpenAlex
- W2088878850
- Cited by
- 28
- References
- 40
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 3 · 2020: 2 · 2019: 2 · 2018: 5 · 2017: 2 · 2016: 5 · 2015: 2 · 2014: 2
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Hadassah Medical Organization
- Israel Science Foundation (1169/09)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- liver fibrosis, TLR9, natural killer cells, hepatic stellate cells, CpG oligodeoxynucleotides, carbon tetrachloride-induced liver injury, CD8+ T cells, cellular senescence, adoptive transfer, antifibrotic therapy, liver inflammation
- MeSH terms
- Adjuvants, Immunologic, Animals, Carbon Tetrachloride Poisoning, Cell Communication, Killer Cells, Natural, Liver Cirrhosis, Oligodeoxyribonucleotides, Mice, Knockout, CD8-Positive T-Lymphocytes, Adoptive Transfer, Toll-Like Receptor 9, Mice, Hepatic Stellate Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.